Menu
Recruiting NCT06138925

Analysis of the Psychometric Properties of Kinematic Parameters of Locomotion Measured by Inertial Measurement Units. Validation in Healthy Children and Children With Cerebral Palsy

No phase Interventional Cerebral Palsy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Analysis of walking, Analysis of running, Analysis of walking.
Who it may be relevant to
Registry conditions: Cerebral Palsy. Basic parameters: 7 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Cerebral palsy (CP) is currently one of the major causes of disability in children. The presence of various disorders (muscle stiffness, architectural bone defects, spasticity) leads to a number of functional impacts, including severe impairment of mobility, particularly locomotion. Locomotion can be assessed using a motion capture system that enables 3-dimensional analysis, in order to help make treatment decisions and quantify them. Although these systems are currently considered to be the gold standard, the fact remains that they cause a certain amount of patient fatigue (long set-up times) and that walking is assessed in a laboratory rather than in real life. Today, technological advances have brought to the fore other gait analysis devices, such as inertial measurement units (IMUs). Various systems incorporating IMUs in the feet, for example, respond to these problems of analysing walking in real-life situations. The IMUs record the movements and orientation of the foot in space; the data is then processed by algorithms to recognise walking steps and calculate the spatio-temporal parameters of locomotion. Additional IMUs positioned on the body can be grafted onto this system to provide a more precise analysis of locomotion, in particular by calculating the movements of the various joints of the lower limb. However, before such devices can be used in a pathological paediatric population, they must be validated in a healthy population. This validation must be conducted using a precise method that has been widely documented in the COSMIN recommendations (Consensus-based Standards for the selection of health Measurement Instruments). The first stage will assess the safety of the IMU devices in a healthy paediatric population, and the validity of the spatio-temporal parameters. If these properties are deemed to be compliant, these same parameters will be assessed in a paediatric population with cerebral palsy in the second stage.

Interventions

  • Other Analysis of walking
    3-dimensional gait analysis with inertial measurement units (IMUs) on flat ground at different speeds (slow, comfortable and fast)
  • Other Analysis of running
    analysis of running on flat ground at different speeds (comfortable and fast)
  • Other Analysis of walking
    3-dimensional gait analysis with inertial measurement units (IMUs) on flat ground at spontaneous speed (comfortable).

Primary outcome measures

  • Walking speed [Time frame: During the study visit]

Eligibility criteria

Inclusion criteria

  • Children who have given their consent and whose legal representatives have given their consent
  • Age between 7 and 17 years,
  • Children able to understand simple commands and instructions.
  • Children living within a maximum radius of 50 km of the investigation site.
  • Child covered by national health insurance.

PATIENT GROUP (IN ADDITION TO THOSE ABOVE)

  • Children with proven cerebral palsy resulting in locomotor impairment but able to move around without technical aids (cane, wheelchair).
  • Child covered by national health insurance.

Exclusion criteria

  • Children with a condition other than cerebral palsy that affects their ability to walk.
  • Child subject to a measure of legal protection
  • A child unable to give consent
  • Pregnant, parturient or breast-feeding participant

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • Chu Dijon Bourgogne — Dijon

Identifiers

NCT: NCT06138925 · ORNETTI 2023

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗